Cohen Joshua B - Insider Non-Derivative Transactions at Amylyx Pharmaceuticals, Inc. (AMLX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Sep 30, 2025, Cohen Joshua B's relationship to Amylyx Pharmaceuticals, Inc. (AMLX) is Director,Officer (Co-Chief Executive Officer), and currently has 3,325,547 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AMLX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Cohen Joshua B - Insider Non-Derivative Transactions of AMLX Common Stock

Cohen Joshua B - Insider Non-Derivative Transactions at AMLX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 1, 2025	Sell -- (Common Stock)	200	15	3325347
Oct 1, 2025	Sell -- (Common Stock)	29733	14.34	3325547
Apr 1, 2025	Sell -- (Common Stock)	21490	3.47	3355280
Mar 7, 2025	Acquisition -- (Common Stock)	180118	0	3376770
Mar 4, 2025	Sell -- (Common Stock)	4595	3.17	3196652
Feb 4, 2025	Sell -- (Common Stock)	11851	3.47	3201247
Jan 7, 2025	Sell -- (Common Stock)	7471	4.05	3213098
Oct 1, 2024	Sell -- (Common Stock)	18589	3.2	3220569
Sep 24, 2024	M -- (Common Stock)	1857	1.57	3239158
Sep 13, 2024	M -- (Common Stock)	34449	1.57	3237301
Apr 17, 2024	Acquisition -- (Common Stock)	179850	0	3202852
Mar 6, 2024	Sell -- (Common Stock)	4135	18.73	3023002
Feb 27, 2024	Acquisition -- (Common Stock)	126667	0	3027137
Jan 10, 2024	Sell -- (Common Stock)	5841	16.33	2900470
Nov 17, 2023	M -- (Common Stock)	63694	1.57	2906311
Mar 17, 2023	Sell -- (Common Stock)	3924	32.45	2792617
Mar 17, 2023	Sell -- (Common Stock)	96076	31.84	2796541
Mar 17, 2023	Acquisition -- (Common Stock)	50000	0	2842617
Jan 7, 2023	Sell -- (Common Stock)	1846	36.79	2892617
Jan 7, 2023	Sell -- (Common Stock)	4122	36.08	2894463